Analysis of sertraline in postmortem fluids and tissues in 11 aviation accident victims

Journal of Analytical Toxicology

Volumn 37, Issue 4, 2013, Pages 208-216

  Lewis, Russell J ^a   Angier, Mike K ^a   Williamson, Kelly S ^a   Johnson, Robert D ^b  

^a CIVIL AEROSPACE MEDICAL INSTITUTE   (United States)

^b Tarrant County Medical Examiner's Office   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HELIUM; NORSERTRALINE; SERTRALINE;

AIRCRAFT ACCIDENT; ARTICLE; BILE; BLOOD; BRAIN; CALIBRATOR; HEART; HUMAN; HUMAN TISSUE; KIDNEY; LIVER; LUNG; MASS FRAGMENTOGRAPHY; MUSCLE; SOLID PHASE EXTRACTION; SPLEEN; URINE; VICTIM; VITREOUS BODY;

ACCIDENTS, AVIATION; ADULT; AGED; ANTIDEPRESSIVE AGENTS; AUTOPSY; BODY FLUIDS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SOLID PHASE EXTRACTION; SPECIMEN HANDLING; TISSUE DISTRIBUTION;

EID: 84876054673     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bkt014     Document Type: Article

References (29)

1. Wille, S.M., Cooreman, S.G., Neels, H.M., Lambert, W.E. (2008) Relevant issues in the monitoring and the toxicology of antidepressants. Critical Reviews in Clinical Laboratory Sciences, 45, 25-89.
2. Block, D.R., Yonkers, K.A., Carpenter, L.L. (2009) Sertraline. In Schatzberg, A.F., Nemeroff, C.B. (eds.), Textbook of psychopharmacology, 4th edition, Chapter 14. American Psychiatric Publishing, Inc., Washington, D.C., pp. 307-320.
3. (2012) Zoloft (Sertraline Hydrochloride) Package Insert, Pfizer Inc., Roering Division.
4. MacQueen, G., Born, L., Steiner, M. (2001) The selective serotonin reuptake inhibitor sertraline: Its profile and use in psychiatric disorders. CNS Drug Reviews, 7, 1-24.
5. Logan, B.K., Friel, P.N., Case, G.A. (1994) Analysis of sertraline (zoloft) and its major metabolite in postmortem specimens by gas and liquid chromatography. Journal of Analytical Toxicology, 18, 139-142.
6. DeVane, C.L., Liston, H.L., Markowitz, J.S. (2002) Clinical pharmacokinetics of sertraline. Clinical Pharmacokinetics, 41, 1247-1266.
7. Hiemke, C., Hartter, S. (2000) Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacology And Therapeutics, 85, 11-28.
8. Tremaine, L.M., Welch, W.M., Ronfeld, R.A. (1989) Metabolism and disposition of the 5-hydroxytryptamine uptake blocker sertraline in the rat and dog. Drug Metabolism and Disposition, 17, 542-550.
9. Warrington, S.J. (1991) Clinical implications of the pharmacology of sertraline. International Clinical Psychopharmacology, 6, 11-21.
10. Obach, R.S., Cox, L.M., Tremaine, L.M. (2005) Sertraline is metabolized by multiple cytochrome p450 enzymes, monoamine oxidases, and glucuronyl transferases in human: An in vitro study. Drug Metabolism and Disposition, 33, 262-270.
11. DeVane, C.L. (1999) Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors. Cellular and Molecular Neurobiology, 19, 443-466.
12. Levine, B., Jenkins, A.J., Smialek, J.E. (1994) Distribution of sertraline in postmortem cases. Journal of Analytical Toxicology, 18, 272-274.
13. Moffat, A.C., Osselton, M.D., Widdop, B. (eds) (2004) Clarke's analysis of drugs and poisons in pharmaceuticals, body fluids, and postmortem materials, 3rd edition. Pharmaceutical Press, London, UK.
14. Han, E., Kim, E., Hong, H., Jeong, S., Kim, J., In, S. et al. (2012) Evaluation of postmortem redistribution phenomena for commonly encountered drugs. Forensic Science International, 219, 265-271.
15. Rodda, K.E., Drummer, O.H. (2006) The redistribution of selected psychiatric drugs in post-mortem cases. Forensic Science International, 164, 235-239.
16. Baselt, R.C. (2002) Disposition of toxic drugs and chemicals in man, 6th edition. Biomedical Publications, Foster City, CA, pp. 1422-1424.
17. Kassner, J., Woolf, A. (1993) Sertraline hydrochloride: Correlation of clinical presentation with plasma concentration-Abstract. Veterinary And Human Toxicology, 35, 341.
18. Goeringer, K.E., Raymon, L., Christian, G.D., Logan, B.K. (2000) Postmortem forensic toxicology of selective serotonin reuptake inhibitors: A review of pharmacology and report of 168 cases. Journal of Forensic Sciences, 45, 633-648.
19. Leikin, J.B., Watson, W.A. (2003) Post-mortem toxicology: What the dead can and cannot tell us. Journal of Toxicology-Clinical Toxicology, 41, 47-56.
20. Pelissier-Alicot, A.L., Gaulier, J.M., Champsaur, P., Marquet, P. (2003) Mechanisms underlying postmortem redistribution of drugs: A review. Journal of Analytical Toxicology, 27, 533-544.
21. Tracqui, A., Kintz, P., Ritter-Lohner, S., Mangin, P., Lugnier, A., Chaumont, A. (1990) Toxicological findings after fatal amitriptyline self-poisoning. Human And Experimental Toxicology, 9, 257-261.
22. Moore, K.A., Levine, B., Smith, M.L., Saki, S., Schames, J., Smialek, J.E. (1999) Tissue distribution of mirtazapine (remeron) in postmortem cases. Journal of Analytical Toxicology, 23, 541-543.
23. Levine, B., Zhang, X., Smialek, J.E., Kunsman, G.W., Frontz, M.E. (2001) Citalopram distribution in postmortem cases. Journal of Analytical Toxicology, 25, 641-644.
24. Bynum, N.D., Poklis, J.L., Gaffney-Kraft, M., Garside, D., Ropero-Miller, J.D. (2005) Postmortem distribution of tramadol, amitriptyline, and their metabolites in a suicidal overdose. Journal of Analytical Toxicology, 29, 401-406.
25. Rollins, D.E., Klaassen, C.D. (1979) Biliary excretion of drugs in man. Clinical Pharmacokinetics, 4, 368-379.
26. Rozman, K.K., Klassen, C.D. (2001) Absorption, distribution, and excretion of toxicants. In Klassen, C.D. (ed.), Casarett and Doull's toxicology: The basic science of poisons, 6th edition, Chapter 5. McGraw-Hill, New York, NY, pp. 107-132.
27. Drummer, O.H. (2004) Postmortem toxicology of drugs of abuse. Forensic Science International, 142, 101-113.
28. Skopp, G. (2004) Preanalytic aspects in postmortem toxicology. Forensic Science International, 142, 75-100.
29. Skopp, G. (2010) Postmortem toxicology. Forensic Science, Medicine, and Pathology, 6, 314-325.